Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for CVRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 19.95M
March 31, 2026 29.11M
December 31, 2025 39.32M
September 30, 2025 48.05M
June 30, 2025 57.93M
March 31, 2025 69.36M
December 31, 2024 71.06M
September 30, 2024 65.18M
June 30, 2024 55.25M
March 31, 2024 66.26M
December 31, 2023 75.95M
September 30, 2023 82.83M
Date Value
June 30, 2023 89.96M
March 31, 2023 99.64M
December 31, 2022 109.18M
September 30, 2022 118.24M
June 30, 2022 127.15M
March 31, 2022 136.80M
December 31, 2021 145.96M
September 30, 2021 155.76M
June 30, 2021 -318.93M
March 31, 2021 -301.81M
December 31, 2020 -293.24M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
NeuroPace, Inc. 11.88M
Accuray, Inc. 41.70M
Orthofix Medical, Inc. 429.18M
ResMed, Inc. 6.585B
Rockwell Medical, Inc. 35.08M

Shareholders Equity (Quarterly) Related Metrics